Syfovre TM
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: pegcetacoplan
Pack: Syfovre 15 mg/0.1 mL intraocular injection, 0.1 mL vial
Brand name
(ARTG)
: SYFOVRE pegcetacoplan 15 mg/0.1 mL solution for injection vialConsumer Medicine Information (CMI)
Read the CMI leaflet for facts you need to know before, during and after taking your medicine.
For more information about CMIs and how to read them, please visit How to read Consumer Medicine Information (CMI).
What this medicine is used for
(ARTG)
SYFOVRE is indicated for the treatment of adult patients with geographic atrophy (GA) secondary to age-related macular degeneration (AMD) with an intact fovea and when central vision is threatened by GA lesion growth. The benefits and risks of intravitreal pegcetacoplan should be discussed with the patient prior to commencing treatment. SYFOVRE should be administered by an eye specialist experienced in the management of geographic atrophy.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Injection, solution
- Intravitreal-Within The Vitreous Cavity Of The Eye
- clear, colourless to light yellow solution essentially free of visible particulates in a glass vial, with a rubber stopper, aluminium seal and polypropylene flip off cap
Storage conditions
(ARTG)
- Store at 2 to 8 degrees Celsius
- Protect from Light
- Do not Freeze
- Refrigerate
- Shelf lifetime is 18 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is
- 1 vial pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient pegcetacoplan
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
This medicine is under additional monitoring as it is new or being used in a different way. You can help identify new safety information by reporting any side effects you may get.
- You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems.
- For more information on the Black Triangle Scheme and how to report side effects, see www.tga.gov.au/black-triangle-scheme
